Category Archives: Personalized Medicine

Follow The Patients: The Case For Neuroscience And Other “Challenging” Fields
September 11, 2014

This blog was written by Ankit Mahadevia, CBO of Rodin Therapeutics and Spero Therapeutics, as part of the “From the Trenches” feature of LifeSciVC. There’s an ebb and flow in our business around interest in specific therapeutic areas; hot TAs such

Leave a comment

Unhealthy Prognosis for Venture-Backed Diagnostics
April 26, 2013

Personalized medicine and diagnostics are undoubtedly critical to the delivery of better healthcare in the future: getting the right drug to the right patient at the right time.  In theory, these therapy-guiding diagnostics should reduce the cost of healthcare while

2 Comments

On-Q-ity, a Cancer Diagnostic Company: R.I.P.
April 10, 2013

Not every deal is a winner, and unfortunately On-Q-ity wasn’t.  After a few years of hammering away at its diagnostic business case, the board decided to wind the company down back in November and we are just completing the sale

20 Comments